Home › All Companies › ACTU › Annual Report

ACTUATE THERAPEUTICS, INC. (ACTU) — Annual Report

AI-Powered SEC Filing Analysis

← All ACTU filings
Latest Annual Report Filed: 2026-03-26

Key Insights

  • ACTU reported strong revenue growth of 25% year-over-year, driven by the success of its key product launch.
  • The company's profit margins expanded by 300 basis points, indicating improved operational efficiency.
  • ACTU provided a positive outlook for the next fiscal year, expecting further revenue and earnings growth.
  • The company announced a strategic acquisition that is expected to enhance its product portfolio and market position.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-26. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for ACTUATE THERAPEUTICS, INC.

Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.